Oct 09, 2016 14:00 pm UTC| Business
SAN DIEGO, Oct. 09, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Oct 09, 2016 14:00 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Oct. 09, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today announced a poster presentation of updated data on its lead...
Oct 09, 2016 11:00 am UTC| Business
HAMPTON, N.J., Oct. 09, 2016 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today presented positive results from the Company’s Phase 2 study of glembatumumab vedotin in patients with stage III/IV checkpoint...
Oct 09, 2016 10:00 am UTC| Business
NEW YORK, Oct. 09, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against The GEO Group, Inc. (“GEO” or the “Company”) (NYSE:GEO) and certain of its officers. The class action, filed in...
Oct 09, 2016 10:00 am UTC| Business
NEW YORK, Oct. 09, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Correction Corporation of America (“CCA” or the “Company”) (NYSE:CXW) and certain of its officers. The class action,...
Oct 09, 2016 10:00 am UTC| Business
NEW YORK, Oct. 09, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Goldcorp Inc. (“Goldcorp” or the “Company”) (NYSE:GG) and certain of its officers. The class action, filed in United...
Oct 09, 2016 10:00 am UTC| Business
NEW YORK, Oct. 09, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against Concordia International Corp. (“Concordia” or the “Company”) (NASDAQ:CXRX) and certain of its officers. The class...